




Preparing video
Michael McCarthy from Moomoo Australia observes ongoing positive momentum in the Australian market. Trading shows gains across most sectors, notably tech and biotechnology, with BHP and Rio under pressure due to weaker metals prices. Insignia Financial sees interest from CCI for a $2.9 billion takeover offer.
Michael mentions that 2023 delivered excellent returns for investors, highlighting impressive US market growth driven by tech stocks. The Australian market, while not matching US performance, saw strong developments, especially in biotech stocks like Mesoblast with a significant increase of 900%, boosted by FDA approvals.
Zip reports a strong year transitioning from speculation to solid revenue-driven growth. Conversely, Michael points out challenges for lithium firms, like Liontown Resources, experiencing a downturn amid an oversupplied market and alternative technology pressures. The outlook remains cautious yet hopeful.